Research Topics
Species | Ulrike ScharaSummaryCountry: Germany Publications
| Collaborators
|
Detail Information
Publications
Congenital myasthenic syndromes: current diagnostic and therapeutic approachesUlrike Schara
Department of Neuropediatrics, Developmental Neurology and Social Pediatrics, University of Essen, Essen, Germany
Neuropediatrics 43:184-93. 2012..This article provides an overview of specific clinical symptoms, diagnostic work-up, and care including possible pharmacotherapy in case of CMS...
Long-term follow-up in patients with congenital myasthenic syndrome due to CHAT mutationsUlrike Schara
Dept of Paediatric Neurology, University of Essen, Hufelandstr 55, D 45122 Essen, Germany
Eur J Paediatr Neurol 14:326-33. 2010..Between crises symptoms may be mild and variable. Acetylcholinesterase - inhibitor therapy is reported to improve clinical symptoms and reduce crises...
Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutationsU Schara
Dept of Pediatric Neurology, University of Essen, Germany
Neuromuscul Disord 19:828-32. 2009..These investigations are appropriate to confirm the diagnosis in case of pathological results, but they might not be appropriate means to monitor patients under ephedrine therapy...
Therapeutic strategies in congenital myasthenic syndromesUlrike Schara
Department of Pediatric Neurology, University of Essen, Essen, Germany
Neurotherapeutics 5:542-7. 2008..In most CMS, however, mild and severe clinical courses are reported, which makes assessment on an individual basis necessary. This review emphasizes therapeutic strategies in CMS...
The phenotype and long-term follow-up in 11 patients with juvenile selenoprotein N1-related myopathyUlrike Schara
Department of Pediatric Neurology, University of Essen, Germany
Eur J Paediatr Neurol 12:224-30. 2008..Major complications were early respiratory failure, impaired increase in weight and orthopedic problems. There seems to be no correlation between skeletal muscle weakness and respiratory failure...
Acute liver failure with subsequent cirrhosis as the primary manifestation of TRMU mutationsUlrike Schara
Pediatric Neurology, University of Essen, Essen, Germany
J Inherit Metab Dis 34:197-201. 2011..We suggest that TRMU deficiency should be considered in infants with acute liver disease...
Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromesJuliane S Muller
Friedrich Baur Institute, Department of Neurology, Ludwig Maximilians University, Munich, Germany
Brain 130:1497-506. 2007....
Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromesVioleta Mihaylova
Friedrich Baur Institute, Department of Neurology, Ludwig Maximilians University, Munich, Germany
Brain 131:747-59. 2008..Moreover, overlap with other CMS subtypes and potentially absence of a repetitive compound muscle action potential should be considered in the diagnosis of COLQ-mutated patients...
CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsynJuliane S Muller
Department of Neurology, Friedrich Baur Institute, Ludwig Maximilians University, Munich, Germany
Brain 129:2784-93. 2006..Introduction of the same mutation in the epsilon subunit had no effect on AChR clustering indicating a special role of the delta subunit in AChR-rapsyn interactions...
A newly identified chromosomal microdeletion of the rapsyn gene causes a congenital myasthenic syndromeJuliane S Muller
Department of Neurology and Gene Center, Friedrich Baur Institute, Ludwig Maximilians University, Munich, Germany
Neuromuscul Disord 14:744-9. 2004..Interestingly, an Alu-mediated unequal homologous recombination may have caused the deletion. We hypothesize that numerous interspersed Alu elements may predispose the RAPSN locus for genetic rearrangements...
Transcriptional profiles from patients with dystrophinopathies and limb girdle muscular dystrophies as determined by qRT-PCRLarissa Arning
Human Genetics, Ruhr-University, , 44801 Bochum, Germany
J Neurol 251:72-8. 2004..Our results define a uniform transcriptional profile of the dystrophic muscle characterized by degeneration and regeneration. Several genes encoding structural proteins appear remarkably highly expressed...
Severe mucous membrane involvement in epidermolysis bullosa simplex with muscular dystrophy due to a novel plectin gene mutationUlrike Schara
Department of Paediatrics and Paediatric Neurology, Ruhr University Bochum, Alexandrinenstrasse 5, 44791 Bochum, Germany
Eur J Pediatr 163:218-22. 2004..CONCLUSION: The complete lack of protein expression, which may be attributed to a nonsense-mediated plectin mRNA decay, is likely to cause muscular dystrophy and other multisystem involvement later in life...
X-linked myotubular myopathy in a female infant caused by a new MTM1 gene mutationUlrike Schara
Department of Pediatrics and Pediatric Neurology, Ruhr University Bochum, Germany
Neurology 60:1363-5. 2003..The authors describe a now 5-year-old girl with prenatal/neonatal onset of an X-linked myotubular myopathy due to a 605delT mutation in the myotubularin gene...
Rippling muscle disease in childhoodUlrike Schara
Department of Pediatrics, Ruhr University Bochum, Germany
J Child Neurol 17:483-90. 2002..Muscle biopsy must be considered in patients without muscle weakness or mechanical hyperirritability to differentiate between rippling muscle disease and limb-girdle muscular dystrophy 1C...
